A mostrar 1 - 1 resultados de 1 para a pesquisa 'for the PRESS XII study group', tempo de pesquisa: 0.04seg Refinar resultados
  1. 1
    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)

    Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double bli... Por Manjunath Krishnappa, Kishor Patil, Krupi Parmar, Purav Trivedi, Nirali Mody, Chintan Shah, Khushboo Faldu, Sanjay Maroo, for the PRESS XII study group, Deven Parmar

    Publicado em 2020-06-01
    Obter o texto integral
    Artigo

Ferramentas de pesquisa: